Should schizophrenia be treated as a neurocognitive disorder?

Schizophrenia Bulletin

Volumn 25, Issue 2, 1999, Pages 309-319

  Green, Michael Foster ^a,b   Nuechterlein, Keith H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotic medication; Cognition; Cognitive remediation; Functional outcome; Neurocognition

Indexed keywords

BENZATROPINE MESILATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOSERINE; GLUTAMATE RECEPTOR; NEUROLEPTIC AGENT;

BEHAVIOR THERAPY; COGNITIVE DEFECT; COGNITIVE THERAPY; HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0033018320     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033380     Document Type: Review

References (65)

1. Bellack, A.S.; Gold, J.M.; and Buchanan, R.W. Cognitive rehabilitation for schizophrenia: Problems, prospects, and strategies. Schizophrenia Bulletin, 25(2):257-274, 1999.
2. Benedict, R.H.B.; Harris, A.E.; Markow, T.; McCormick, J.A.; Nuechterlein, K.H.; and Asarnow, R.F. Effects of attention training on information processing in schizophrenia. Schizophrenia Bulletin, 20:537-546, 1994.
3. Bleuler, E. Dementia Praecox or the Group of Schizophrenias. New York, NY: International Universities Press, 1950.
4. Braff, D. Information processing and attention dysfunctions in schizophrenia. Schizophrenia Bulletin, 19:233-259, 1993.
5. Brekke, J.S.; Raine, A.; Ansel, M.; and Lencz, T. Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia. Schizophrenia Bulletin, 23:19-28, 1997.
6. Brenner, H.D.; Kraemer, S.; Hermanutz, M.; and Hodel, B. Cognitive treatment in schizophrenia. In: Straube, E.R., and Halweg, K., eds. Schizophrenia: Concepts, Vulnerability, and Interventions. New York, NY: Springer-Verlag, 1990. pp. 161-192.
7. Bryson, G.; Bell, M.; and Lysaker, P. Affect recognition in schizophrenia: A function of global impairment or a specific cognitive deficit. Psychiatry Research, 71:105-113, 1997.
8. Buchanan, R.W.; Holstein, C.; and Breier, A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biological Psychiatry, 36:717-725, 1994.
9. Buchanan, R.W.; Strauss, M.E.; Breier, A.; Kirkpatrick, B.; and Carpenter, W.T. Attentional impairments in deficit and nondeficit forms of schizophrenia. American Journal of Psychiatry, 154:363-370, 1997.
10. Cassens, G.; Inglis, A.K.; Appelbaum, P.S.; and Gutheil, T.G. Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients. Schizophrenia Bulletin, 16:477-499, 1990.
11. Censits, D.M.; Ragland, J.D.; Gur, R.C.; and Gur, R.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: A longitudinal study. Schizophrenia Research, 24:289-298, 1997.
12. Chapman, L.J., and Chapman, J.P. Problems in the measurement of cognitive deficit. Psychology Bulletin, 79:380-385, 1973.
13. Cornblatt, B.A.; Lenzenweger, M.F.; Dworkin, R.H.; and Erlenmeyer-Kimling, L. Positive and negative schizophrenic symptoms, attention, and information processing. Schizophrenia Bulletin, 11:397-408, 1985.
14. Cornblatt, B.; Lenzenweger, M.F.; Dworkin, R.; and Erlenmeyer-Kimling, L. Childhood attentional dysfunction predicts social deficits in unaffected adults at risk for schizophrenia. British Journal of Psychiatry, 161(Suppl. 18):59-64, 1992.
15. Cornblatt, B.; Obuchowski, M.; Schnur, D.B.; and O'Brien, J.D. Attention and clinical symptoms in schizophrenia. Psychiatric Quarterly, 68:343-359, 1997.
16. Cuesta, M.J., and Peralta, V. Lack of insight in schizophrenia. Schizophrenia Bulletin, 20:359-366, 1994.
17. Davidson, M., and Keefe, R.S.E. Cognitive impairment as a target for pharmacological treatment in schizophrenia. Schizophrenia Research, 17:123-129, 1995.
18. Davies, D.R., and Parasuraman, R. The Psychology of Vigilance. London, England: Academic Press, 1982.
19. Dickerson, F.; Boronow, J.J.; Ringel, N.; and Parente, F. Neurocognitive deficits and social functioning in outpatients with schizophrenia. Schizophrenia Research, 21:75-83, 1996.
20. Dickerson, F.B.; Boronow, J.J.; Ringel, N.; and Parente, F. Lack of insight among outpatients with schizophrenia. Psychiatric Services, 48:195-199, 1997.
21. Drachman, D.A., and Leavitt, J. Human memory and the cholinergic system. Archives of Neurology, 30:113-121, 1974.
22. Frith, C.D., and Done, D.J. Towards a neuropsychology of schizophrenia. British Journal of Psychiatry, 153:437-443, 1988.
23. Fuster, J.M. The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. New York, NY: Raven Press, 1989.
24. Goff, D.C.; Tsai, G.; Manoach, D.S.; and Coyle, J.T. Dose-finding trial for D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. American Journal of Psychiatry, 152:1213-1215, 1995.
25. Goldberg, T.E.; Gold, J.M.; Greenberg, R.; and Griffin, S. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. American Journal of Psychiatry, 150:1355-1362, 1993.
26. Goldman-Rakic, P.S. Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory. In: Carroll, B.J., and Barrett, J.E., eds. Psychopathology and the Brain. New York, NY: Raven Press, 1991. pp. 1-23.
27. Goldstein, G. Cognitive and perceptual differences between schizophrenics and organics. Schizophrenia Bulletin, 4:160-185, 1978.
28. Green, M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153:321-330, 1996.
29. Green, M.F.; Marshall, B.D.; Wirshing, W.C.; Ames, D.; Marder, S.R.; McGurk, S.; Kern, R.S.; and Mintz, J. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? American Journal of Psychiatry, 154:799-804, 1997.
30. Green, M.F.; Nuechterlein, K.H.; and Gaier, D.J. Sustained and selective attention in schizophrenia. Progress in Experimental Personality and Psychopathology Research, 15:290-313, 1992.
31. Green, M.F., and Walker, E. Neuropsychological performance and positive and negative symptoms in schizophrenia. Journal of Abnormal Psychology, 94:460-469, 1985.
32. Hagger, C.; Buckley, P.; Kenny, J.T.; Friedman, L.; Ubogy, D.; and Meltzer, H.Y. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry, 34:702-712, 1993.
33. Harvey, P.D.; Davidson, M.; Mueser, K.T.; Parrella, M.; White, L.; and Powchik, P. Social-adaptive functioning evaluation (SAFE): A rating scale for geriatric psychiatric patients. Schizophrenia Bulletin, 23:131-139, 1997.
34. Hemsley, D.R. Perceptual and cognitive abnormalities as the bases for schizophrenic symptoms. In: Anthony, D.S., and Cutting, J.C., eds. The Neuropsychology of Schizophrenia. Hove, UK: Lawrence Erlbaum Associates, 1994. pp. 97-116.
35. Jeste, D.V.; Lohr, J.B.; Eastman, J.H.; Rockwell, E.; and Caligiuri, M.P. Adverse neurobiological effects of long-term use of neuroleptics: Human and animal studies. Journal of Psychiatric Research, 32:201-214, 1998.
36. Keefe, R.S.E.; Silva, S.G.; Perkins, D.O.; and Lieberman, J.A. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophrenia Bulletin, 25(2):201-222, 1999.
37. Kern, R.S.; Green, M.F.; Marshall, B.D.; Wirshing, W.C.; Wirshing, D.; McGurk, S.R.; Marder, S.R.; and Mintz, J. Risperidone vs. haloperidol on secondary memory: Can newer antipsychotic medications aid learning? Schizophrenia Bulletin, 25(2):223-233, 1999.
38. Kraepelin, E. Dementia Praecox and Paraphrenia [1913/1919]. Huntington, NY: Robert E. Krieger Publishing Co. Inc., 1971.
39. Loehlin, J.C. Latent Variable Models: An Introduction to Factor, Path, and Structural Analysis. Hillsdale, NJ: Lawrence Erlbaum Associates, 1987.
40. Lysaker, P., and Bell, M. Insight and cognitive impairment in schizophrenia: Performance on repeated administrations of the Wisconsin Card Sorting Test. Journal of Nervous and Mental Disease, 182:656-660, 1994.
41. Medalia, A.; Aluma, M.; Tryon, W.; and Merriam, A. Effectiveness of attention training in schizophrenia. Schizophrenia Bulletin, 24:147-152, 1998.
42. Meehl, P.E. High school yearbooks: A reply to Schwartz. Journal of Abnormal Psychology, 77:143-148, 1971.
43. Meltzer, H.Y., and McGurk, S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin, 25(2):233-255, 1999.
44. Mueser, K.T.; Doonan, B.; Penn, D.L.; Blanchard, J.J.; Bellack, A.S.; Nishith, P.; and DeLeon, J. Emotion perception and social competence in chronic schizophrenia. Journal of Abnormal Psychology, 105:271-275, 1996.
45. Nuechterlein, K.H. Vigilance in schizophrenia and related disorders. In: Steinhauer, S.R.; Gruzelier, J.H.; and Zubin, J., eds. Handbook of Schizophrenia. Amsterdam, The Netherlands: Elsevier, 1991. pp. 397-433.
46. Nuechterlein, K.H., and Dawson, M.E. Information processing and attentional functioning in the developmental course of schizophrenia disorders. Schizophrenia Bulletin, 10:160-203, 1984.
47. Nuechterlein, K.H.; Dawson, M.E.; Gitlin, M.; Ventura, J.; Goldstein, M.J.; Snyder, K.S.; Yee, C.M.; and Mintz, J. Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin, 18:387-425, 1992.
48. Nuechterlein, K.H.; Dawson, M.E.; and Green, M.F. Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatrica Scandinavica, 90(Suppl. 384):71-79, 1994.
49. Nuechterlein, K.H.; Edell, W.S.; Norris, M.; and Dawson, M.E. Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophrenia Bulletin, 12:408-426, 1986.
50. Nunnally, J.M. Psychometric Theory. New York, NY: McGraw-Hill, 1978.
51. Olney, J.W., and Farber, N.B. Glutamate receptor dysfunction and schizophrenia. Archives of General Psychiatry, 52:998-1007, 1995.
52. Penn, D.L.; Corrigan, P.W.; Bentall, R.P.; Racenstein, J.M.; and Newman, L. Social cognition in schizophrenia. Psychological Bulletin, 121:114-132, 1997.
53. Penn, D.L.; Spaulding, W.D.; Reed, D.; and Sullivan, M. The relationship of social cognition toward behavior in chronic schizophrenia. Schizophrenia Research, 20:327-335, 1996.
54. Robbins, T.W., and Everitt, B.J. Arousal systems and attention. In: Gazzaniga, M.S., ed. The Cognitive Neurosciences. Cambridge, MA: MIT Press, 1995. pp. 703-720.
55. Schneider, F.; Gur, R.C.; Gur, R.E.; and Shtasel, D.L. Emotional processing in schizophrenia: Neurobehavioral probes in relation to psychopathology. Schizophrenia Research, 17:67-75, 1995.
56. Shakow, D. Segmental set: A theory of the formal psychological deficit in schizophrenia. Archives of General Psychiatry, 6:1-17, 1962.
57. Silverstein, M.L., and Zerwic, M.J. Clinical psychopathologic symptoms in neuropsychologically impaired and intact schizophrenics. Journal of Consulting and Clinical Psychology, 53:267-268, 1985.
58. Spaulding, W.D.; Fleming, S.K.; Reed, D.; Sullivan, M.; Storzbach, D.; and Lam, M. Cognitive functioning in schizophrenia: Implications for psychiatric rehabilitation. Schizophrenia Bulletin, 25(2):275-289, 1999.
59. Spitzer, M. A cognitive neuroscience view of schizophrenic thought disorder. Schizophrenia Bulletin, 23:29-50, 1997.
60. Spohn, H.E., and Strauss, M.E. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology, 98:367-380, 1989.
61. Strauss, M.E. Relations of symptoms to cognitive deficits in schizophrenia. Schizophrenia Bulletin, 19:215-231, 1993.
62. Sweeney, J.A.; Keilp, J.G.; Haas, G.L.; Hill, J.; and Weiden, P.J. Relationships between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Research, 37:297-308, 1991.
63. Velligan, D.I.; Mahurin, R.K.; Diamond, P.L.; Hazelton, B.C.; Eckert, S.L.; and Miller, A.L. The functional significance of symptomatology and cognitive function in schizophrenia. Schizophrenia Research, 25:21-31, 1997.
64. Wykes, T.; Reeder, C.; Corner, J.; Williams, C.; and Everitt, B. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophrenia Bulletin, 25(2):291-307, 1999.
65. Young, D.A.; Davila, R.; and Scher, H. Unawareness of illness and neuropsychological performance in chronic schizophrenia. Schizophrenia Research, 10:117-124, 1993.